Page last updated: 2024-10-29

isradipine and Hyperlipoproteinemias

isradipine has been researched along with Hyperlipoproteinemias in 2 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.

Research Excerpts

Excerpt	Relevance	Reference
"5 mg isradipine on the low density lipoproteins (LDL) entry into the carotid and femoral arteries of 12 hypertensive patients with primary hyperlipoproteinemia (total cholesterol >6."	5.08	Isradipine lowers human arterial low density lipoprotein retention in vivo. ( Fitscha, P; Kritz, H; O'Grady, J; Sinzinger, H, 1998)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pirich, C	1
Fitscha, P	2
Schmid, P	1
Sinzinger, H	2
Kritz, H	1
O'Grady, J	1

Trials

1 trial available for isradipine and Hyperlipoproteinemias

Article	Year
Isradipine lowers human arterial low density lipoprotein retention in vivo. Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 59, Issue:5 Topics: Adult; Antihypertensive Agents; Arteries; Blood Pressure; Calcium Channel Blockers; Carotid Arteries	1998

Other Studies

1 other study available for isradipine and Hyperlipoproteinemias

Article	Year
Isradipine decreases the entry of radioiodine-labelled low-density lipoproteins into the arterial wall. Blood pressure. Supplement, 1994, Volume: 1 Topics: Adult; Angiography; Arteries; Blood Pressure; Female; Gamma Rays; Humans; Hyperlipoproteinemias; Hyp	1994